Ventricular rate control as an endpoint for treatment of atrial fibrillation

Heart Rhythm

Volumn 1, Issue 2 SUPPL., 2004, Pages 45-51

  Wood, Mark A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Clinical endpoints; Heart rate; Outcomes

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ARTICLE; CATHETER ABLATION; CORRELATION FUNCTION; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; EXERCISE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HEART RHYTHM; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MEASUREMENT; MORTALITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; THROMBOEMBOLISM;

EID: 3042816801     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2004.03.063     Document Type: Article

References (44)

1. Carlsson J. Miketic S. Windeler J. Cuneo A. Haun S. Micus S. Walter S. Tebbe U. for the STAF Investigators Randomized trial of rate-control versus rhythm control in persistent atrial fibrillation. The strategies of treatment on atrial fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690-1691
2. Hohnloser S.H. Kuck K.-H. Lillenthal J. for the PIAF Investigators Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial Lancet 356 2000 1789-1794
3. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825-1833
4. Van Gelder I. Hagens V.E. Bosker H.A. Kingma J.H. Kamp O. Kingma T. Said S.A. Darmanata J.I. Timmermans A.J.M. Tijssen J.G.P. Crijins J.G.M. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834-1840
5. Fuster V. Ryden L.E. Asinger R.W. Cannom D.S. Crijins H.J. Frye R.L. Halperin J.L. Kay G.N. Klein W.W. Levy S. McNamara R.L. Prystowsky E.N. Wann L.S. Wyse D.G. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation Circulation 104 2001 2118-2150
6. Wyse D.G. Selection of endpoints in atrial fibrillation studies J Cardiovasc Electrophysiol 13 2002 S47-S52
7. Raeder E.A. Circadian fluctuations in ventricular response to atrial fibrillation Am J Cardiol 66 1990 1013-1016
8. Hayano J. Sakata S. Okada A. Mukai S. Fujinami T. Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure J Am Coll Cardiol 31 1998 158-166
9. Frykman V. Ayers G.M. Darpo B. Rosenqvist M. What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter Am Heart J 145 2003 67-675
10. Weerasooriya R. Davis M. Powell A. Szili-Torok T. Shah C. Whalley D. Kanagaratnam L. Heddle W. Leitch J. Perks A. Ferguson L. Bulsara M. The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT) J Am Coll Cardiol 41 2003 1697-1702
11. Hohnloser S.H. Kuck K.-H. Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial Pacing Clin Electrophysiol 20 1997 1989-1992
12. Rawles J.M. What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 63 1990 157-161
13. Resnekov L. McDonald L. Electroversion of lone atrial fibrillation and flutter including hemodynamic studies at rest and on exercise Br Heart J 33 1971 339-350
14. Rawles J.M. A mathematical model of left ventricular function in atrial fibrillation Int J Biomed Comput 23 1988 57-68
15. Nobuoka S. Hatano S. Nagashima J. Yoshida A. Adachi H. Imai Y. Shibamoto M. Ikeda K. Miyake F. Determination of the target ventricular rate Tex Heart Inst J 29 2002 10-104
16. Brignole M. Menozzi C. Gasparini M. Bongiorni M.G. Botto G.L. Omeeto R. Bruna C. Vinceti A. Verlato R. on the behalf of the PAF2 Study Investigators An investigation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation Eur Heart J 23 2002 892-900
17. Brignole M. Gianfranchi L. Menozzi C. Alboni P. Musso G. Bongiorni M.G. Gasparini M. Raviele A. Lolli G. Paparella N. Acquarones S. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF Study Europace 1 1999 15-19
18. Hilliard A.A. Hodge D.O. Miller T.D. Gibbons R.J. Patients with atrial fibrillation do not exhibit adequate heart rate control during exercise Circulation 108 2003 IV-491
19. Bhandari A.K. Anderson J.L. Gilbert E.M. Alpert B.L. Henthorn R.W. Waldo A.L. Cullen M.T. Hawkinson R.W. Pritchett E.L. Correlation of symptoms with the occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study Am Heart J 124 1992 381-386
20. Frykman V. Jensen-Urstad M. Ostergren J. Rosenqviust M. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics J Intern Med 250 2001 39-397
21. Hoekstra B.H. Hagans V.E. Bosker H.A. Kingma J.H. Crijins H.J. Van Gelder I.C. Efficacy of rhythm control in symptomatic versus asymptomatic patients with persistent atrial fibrillation. Data on the RACE Study Circulation 108 2003 IV-471
22. Shinbane J.S. Wood M.A. Jensen D.N. Ellenbogen K.A. Fitzpatrick A.P. Scheinman M.M. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 7059-7115
23. Atwood J.E. Sullivan M. Forbes S. Myers J. Pewen W. Olson H.G. Froelicher V.F. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation J Am Coll Cardiol 10 1987 314-320
24. Di Bianco R. Morganroth J. Freitag J.A. Ronan J.A. Lindgren K.M. Donohue D.J. Larca L.J. Chadda J.D. Olukotun A.Y. Effects of nadolol on the spontaneous and exercise-provoked heart rate in patients with chronic atrial fibrillation receiving stable doses of digoxin Am Heart J 108 1984 1121-1127
25. Lang R. Klein H.O. Di Segni E. Gefen J. Sareli P. Libhaber C. David D. Weiss W. Guerrero J. Kaplinsky W. Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study Am Heart J 105 1983 82-825
26. Lundstrom T. Ryden L. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil J Am Coll Cardiol 16 1990 86-90
27. Atwood J.E. Myers J.N. Sullivan M.J. Forbes S.M. Pewen W.F. Froelicher V.F. Diltiazem and exercise performance in patients with chronic atrial fibrillation Chest 93 1988 2-25
28. Steinburg J.S. Katz R.J. Bren G.B. Buff L.A. Varghese P.J. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise J Am Coll Cardiol 9 1987 405-411
29. Kay G.N. Ellenbogen K.A. Guidici M. Redfield M.M. Jenkins L.S. Mianulli M. Wilkoff B. and the APT Investigators The ablate and pace trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation J Interv Card Electrophysiol 2 1998 121-135
30. Brignole M. Gianfranchi L. Menozzi C. Alboni P. Musso G. Bongiorni G. Gasparini M. Raviele A. Lolli G. Paparella N. Acquarone S. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacologic treatment in patients with severely symptomatic paroxysmal atrial fibrillation Circulation 96 1997 2617-2624
31. Lee S.-H. Chen S.-A. Tai C.-I. Chiang C.-E. Wen Z.-C. Cheng J.-J. Ding Y.-A. Chang M.-S. Comparison of quality of life and cardiac performance after complete atrioventricular junctional and atrioventricular junctional modification in patients with medically refractory atrial fibrillation J Am Coll Cardiol 31 1998 637-644
32. Marshall H.J. Harris Z.I. Griffith M.J. Holder R.L. Gammage M.D. Prospective randomized study of ablation and pacing vs. medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm Circulation 99 1999 1587-1592
33. Twidale N. McDonald T. Nave K. Seal A. Comparison of the effect of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation Pacing Clin Electrophysiol 21 1998 641-651
34. Jensen S.M. Bergfeldt L. Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction Pacing Clin Electrophysiol 19 1995 1609-1614
35. Wood M.A. Brown-Mahoney C. Kay G.N. Ellenbogen K.A. Clinical outcomes after ablation and pacing therapy for atrial fibrillation Circulation 101 2000 1138-1144
36. Ozcan C. Jahangir A. Friedman P.A. Patel P.J. Munger T.M. Rea R.F. Lloyd M.A. Packer D.L. Hodge D.O. Gersh B.J. Hammill S.C. Shen W.K. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation N Engl J Med 344 2001 1043-1051
37. Daoud E.G. Weiss R. Bahu M. Knight B.P. Bogun F. Goyal R. Harvey M. Strickberger S.A. Man K.C. Morady F. Effect of an irregular ventricular rhythm on cardiac output Am J Cardiol 78 1996 1433-1436
38. Natale A. Zimerman L. Tommassoni G. Newby K. Leonelli F. Fanelli R. Beheiry S. Pisano E. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance Pacing Clin Electrophysiol 22 1999 1634-1639
39. Ueng K.-C. Tsai T.-P. Tsai C.-F. Wu D.-J. Lin C.-S. Lee S.-H. Chen S.-A. Acute and long term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients and chronic lone atrial fibrillation and normal ventricular response J Cardiovasc Electrophysiol 12 2001 303-309
40. Lam C.T.F. Lau C.-P. Leung S.-K. Tse H.-F. Lee K.L.F. Tang M.-O. Tsang V. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation Europace 2 2000 286-291
41. Lau C.-P. Jiang Z.-Y. Tang M.-O. Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fibrillation Pacing Clin Electrophysiol 21 1998 542-548
42. Simpson C.S. Yee R. Lee J.K. Braney M. Klein G.J. Krahn A.D. Skanes A.C. Safety and feasibility of a novel rate-smoothing ventricular pacing algorithm for atrial fibrillation Am Heart J 142 2001 294-300
43. Duckers H.J. van Hemel N.M. Kelder J.C. Bakema H. Yee R. Effective use of a novel rate-smoothing algorithm in atrial fibrillation by ventricular pacing Eur Heart J 18 1997 1951-1955
44. Yee R. The RASTAFF II Trial. The effects of ventricular rate stabilization pacing on clinical outcomes in atrial fibrillation patients Circulation 108 2003 IV-647